101
Views
13
CrossRef citations to date
0
Altmetric
Brief report

Observational study of sublingual specific immunotherapy in persistent and intermittent allergic rhinitis: the EFESO trial

, , &
Pages 2719-2724 | Accepted 25 Jul 2008, Published online: 12 Aug 2008

References

  • Bousquet J. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update. Allergy 2008;63(Suppl 86):8–1601Bousquet J. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update. Allergy 2008;63(Suppl 86):8–160
  • Canonica GW, Passalacqua G. Noninjection routes for immunotherapy. J Allergy Clin Immunol 2003;111:437–482Canonica GW, Passalacqua G. Noninjection routes for immunotherapy. J Allergy Clin Immunol 2003;111:437–48
  • Dahl R, Kapp A, Colombo G. et al. Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allegic rhinoconjunctivitis. J Allergy Clin Immunol 2006;118:434–403Dahl R, Kapp A, Colombo G. et al. Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allegic rhinoconjunctivitis. J Allergy Clin Immunol 2006;118:434–40
  • Wilson DR, Lima MT. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy 2005; 60:4–124Wilson DR, Lima MT. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy 2005; 60:4–12
  • Calamita Z, Saconato H, Pelá AB. et al. Efficacy of sublingual immunotherapy in asthma: systematic review of randomised-clinical trials using the Cochrane Collaboration method. Allergy 2006;61:1162–725Calamita Z, Saconato H, Pelá AB. et al. Efficacy of sublingual immunotherapy in asthma: systematic review of randomised-clinical trials using the Cochrane Collaboration method. Allergy 2006;61:1162–72
  • Marogna M, Massolo A. The type of sensitizing allergen can affect the evolution of respiratory allergy. Allergy 2006;61: 1209–156Marogna M, Massolo A. The type of sensitizing allergen can affect the evolution of respiratory allergy. Allergy 2006;61: 1209–15
  • Canonica GW. Recommendation for standardization of clinical trials with allergen specific immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) task force. Allergy 2007;62:317–247Canonica GW. Recommendation for standardization of clinical trials with allergen specific immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) task force. Allergy 2007;62:317–24
  • Valovirta E, Jacobsen L, Ljørring C. Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children. Allergy 2006;61:1177–838Valovirta E, Jacobsen L, Ljørring C. Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children. Allergy 2006;61:1177–83
  • Asher MI, Keil U, Anderson HR. et al. International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J, 1995;8:483–919Asher MI, Keil U, Anderson HR. et al. International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J, 1995;8:483–91
  • Durham S, Yang WH, Pedersen MR. et al. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006;117:802–910Durham S, Yang WH, Pedersen MR. et al. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006;117:802–9
  • Penagos M, Compalati E, Tarantini F. Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials. Ann Allergy Asthma Immunol 2006;97:141–811Penagos M, Compalati E, Tarantini F. Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials. Ann Allergy Asthma Immunol 2006;97:141–8
  • Dahl R, Kapp A, Colombo G. et al. Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006; 118: 434–4012Dahl R, Kapp A, Colombo G. et al. Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006; 118: 434–40
  • Jadad A, Rennie D. The randomized controlled trial gets a middle-aged checkup. JAMA 1998;279:319–2013Jadad A, Rennie D. The randomized controlled trial gets a middle-aged checkup. JAMA 1998;279:319–20
  • Sackett DL, Gent M. Controversy in counting and attributing events in clinical trials. N Eng J Med 1979;301:1410–1214Sackett DL, Gent M. Controversy in counting and attributing events in clinical trials. N Eng J Med 1979;301:1410–12
  • Rothwell PM. External validity of randomised controlled trials: ‘to whom do the results of this trial apply?’ Lancet 2005; 365: 82–9315Rothwell PM. External validity of randomised controlled trials: ‘to whom do the results of this trial apply?’ Lancet 2005; 365: 82–93
  • Durham SR, Walker SM, Varga EM. et al. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med 1999; 341:46816Durham SR, Walker SM, Varga EM. et al. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med 1999; 341:468
  • Stephenson BJ. Is this patient taking their medication? JAMA 1993;269:2779–8117Stephenson BJ. Is this patient taking their medication? JAMA 1993;269:2779–81
  • Concato J. Randomized controlled trials, observational studies and the hierarchy of research design. N Eng J Med 2000;342: 1887–9218Concato J. Randomized controlled trials, observational studies and the hierarchy of research design. N Eng J Med 2000;342: 1887–92
  • Feinstein AR. The Architecture of Clinical Research. Philadelphia, PA: WB Saunders, 198519Feinstein AR. The Architecture of Clinical Research. Philadelphia, PA: WB Saunders, 1985
  • Laupacis A. Observational studies of treatment effectiveness: some cautions. Ann Intern Med 2004;140:923–420Laupacis A. Observational studies of treatment effectiveness: some cautions. Ann Intern Med 2004;140:923–4
  • Passalacqua G, Guerra L. Efficacy and safety of sublingual immunotherapy. Ann Asthma Allergy Immunol 2004;93:3–1221Passalacqua G, Guerra L. Efficacy and safety of sublingual immunotherapy. Ann Asthma Allergy Immunol 2004;93:3–12

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.